Håkan Hallberg

Håkan has great experience from health-care, drug development, medical care and private equity. He has been CFO for many companies e.g. Karo Bio (currently Karo Pharma), Segulah and Aleris. He has also been chairman and CEO for the listed dental chain Orasolv and until end of 2022 CEO for Takura.

He was born in 1958 and holds a BSc from Stockholm School of Economics.

Contact information

Håkan Hallberg
CFO

E-mail: hakan.hallberg@takura.se